The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lamond David since 2020.
This trader's CIK number is 1770790.
At the time of last reporting, Lamond David was the Director of Quince Therapeutics, Inc.. (stock ticker symbol QNCX).
Also see all insider trading activities at Quince Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | AMTI | 66,500 | $210,850 | 0 | $0 | 0 | $0 |
| 2021 | AMTI | 25,000 | $1,050,000 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | QNCX | 500,436 | $601,323 | 0 | $0 | 0 | $0 |
| 2021 | QNCX | 100,000 | $3,469,499 | 0 | $0 | 0 | $0 |
| 2020 | QNCX | 93,773 | $4,557,918 | 0 | $0 | 0 | $0 |
1. Applied Molecular Transport Inc. (AMTI)
2. Quince Therapeutics, Inc. (QNCX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-05-20 | AMTI | Buy | 33,000 | 3.08 | 101,640 |
| 2022-05-23 | AMTI | Buy | 33,500 | 3.26 | 109,210 |
| 2021-04-06 | AMTI | Buy | 25,000 | 42.00 | 1,050,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-12-12 | QNCX | Buy | 22,627 | 1.01 | 22,853 |
| 2023-12-13 | QNCX | Buy | 22,627 | 1.00 | 22,627 |
| 2023-12-14 | QNCX | Buy | 22,627 | 1.04 | 23,532 |
| 2023-12-07 | QNCX | Buy | 19,123 | 1.01 | 19,314 |
| 2023-12-06 | QNCX | Buy | 19,123 | 1.02 | 19,505 |
| 2023-12-05 | QNCX | Buy | 19,123 | 1.01 | 19,314 |
| 2023-12-01 | QNCX | Buy | 14,378 | .94 | 13,515 |
| 2023-11-29 | QNCX | Buy | 14,378 | .98 | 14,090 |
| 2023-11-30 | QNCX | Buy | 14,378 | .90 | 12,940 |
| 2023-08-30 | QNCX | Buy | 41,026 | 1.31 | 53,744 |
| 2023-08-31 | QNCX | Buy | 41,026 | 1.32 | 54,154 |
| 2023-08-15 | QNCX | Buy | 107,886 | 1.32 | 142,409 |
| 2023-08-16 | QNCX | Buy | 117,348 | 1.29 | 151,378 |
| 2023-08-17 | QNCX | Buy | 24,766 | 1.29 | 31,948 |
| 2021-03-24 | CRTX | Buy | 50,000 | 33.77 | 1,688,500 |
| 2021-03-04 | CRTX | Buy | 50,000 | 35.62 | 1,780,999 |
| 2020-06-04 | CRTX | Buy | 49,125 | 43.11 | 2,117,778 |
| 2020-05-15 | CRTX | Buy | 5,448 | 49.94 | 272,067 |
| 2020-05-19 | CRTX | Buy | 39,200 | 55.31 | 2,168,073 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lamond David (Director of Quince Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.